Vitrolife AB (publ) (STO:VITR)

Sweden · Delayed Price · Currency is SEK

137.00

-5.60 (-3.93%)

Oct 10, 2025, 5:29 PM CET

-3.93% (1Y)

Market Cap	18.55B
Revenue (ttm)	3.54B
Net Income (ttm)	455.00M
Shares Out	135.42M
EPS (ttm)	3.35
PE Ratio	40.89
Forward PE	32.27
Dividend	1.10 (0.80%)
Ex-Dividend Date	Apr 30, 2025

Volume	62,626
Average Volume	79,363
Open	143.70
Previous Close	142.60
Day's Range	137.00 - 144.70
52-Week Range	126.30 - 252.60
Beta	1.77
RSI	52.27
Earnings Date	Oct 23, 2025

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1989

Employees 1,169

Stock Exchange Nasdaq Stockholm

Ticker Symbol VITR

Full Company Profile